Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / JAZZ - Zymeworks: A Somewhat Complicated Story

JAZZ - Zymeworks: A Somewhat Complicated Story

Jazz Pharmaceuticals plc

2024-07-09 12:12:41 ET

Summary

  • Zymeworks Inc. is a Vancouver-based oncology-focused clinical-stage biopharma firm whose lead candidate is advancing on numerous fronts.
  • The company has significant partnership deals with Jazz Pharmaceuticals and BeiGene, Ltd.
  • The company is well-funded and could have its first FDA approval in hand before the end of 2024.
  • An updated analysis of Zymeworks, Inc. follows in the paragraphs below.

Today, we are putting oncology focused Zymeworks Inc. ( ZYME ) back in the spotlight for the first time since our last article on this small-cap concern back at the beginning of 2023. We update our analysis around this Vancouver, Canada clinical stage biopharma firm below....

For further details see:

Zymeworks: A Somewhat Complicated Story
Stock Information
Company Name: Jazz Pharmaceuticals plc
Stock Symbol: JAZZ
Market: NASDAQ
Website: jazzpharmaceuticals.com
Menu
JAZZ JAZZ Quote JAZZ Short JAZZ News JAZZ Articles JAZZ Message Board
Get JAZZ Alerts

News, Short Squeeze, Breakout and More Instantly...